EUVIMEDEUVIMED entdecken
Crossref

LAGging behind no more: PD-1 has a new immunotherapy partner

Andrew J Gunderson

Immunity · 2024

DOI: 10.1016/j.immuni.2024.09.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2024. Verfasst von Andrew J Gunderson. Beteiligte Einrichtung: Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. E…. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, Lymphocyte Activation Gene 3 Protein, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PD-1 blockade partially reverses T cell exhaustion in cancer patients, but broad responses are still limited. Three studies recently published in Cell illuminate how abrogating LAG-3 and PD-1 synergize to further push effector T cell functionality via distinct molecular mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Programmed Cell Death 1 ReceptorLymphocyte Activation Gene 3 ProteinImmunotherapyNeoplasmsHumansAntigens, CDAnimalsImmune Checkpoint InhibitorsT-Lymphocytes

Substanzen

Programmed Cell Death 1 ReceptorLymphocyte Activation Gene 3 ProteinAntigens, CDImmune Checkpoint InhibitorsPDCD1 protein, humanLag3 protein, human

Autor:innen und Institutionen

  • Pelotonia Institute for Immuno-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA. Electronic address: andrew.gunderson@osumc.edu.

Förderung

  • National Cancer Institute

Zitieren

APA

Gunderson, A. J. (2024). LAGging behind no more: PD-1 has a new immunotherapy partner. Immunity. https://doi.org/10.1016/j.immuni.2024.09.010

Vancouver

Gunderson AJ. LAGging behind no more: PD-1 has a new immunotherapy partner. Immunity. 2024. doi:10.1016/j.immuni.2024.09.010

BibTeX
@article{Gunderson2024,
  author = {Gunderson, Andrew J},
  title = {LAGging behind no more: PD-1 has a new immunotherapy partner},
  journal = {Immunity},
  year = {2024},
  doi = {10.1016/j.immuni.2024.09.010}
}
Kostenlos starten →